Japanese Pharmaceutical Consortium Chooses Biacore to Expedite Proteomics Research
08 juil. 2002 06h11 HE
|
Biacore
UPPSALA, Sweden, July 8, 2002 (PRIMEZONE) -- Biacore AB today announced that the Reverse Proteomics Research Institute, Co., Ltd (REPRORI), a consortium of 11 major Japanese companies involved with...
Medivir Interim Report, 1 Jan.-30 June 2002
08 juil. 2002 03h18 HE
|
Medivir
HUDDINGE, Sweden, July 8, 2002 (PRIMEZONE) -- Medivir:
-- MIV-310 demonstrated powerful antiviral effect on patients with
multiresistant HIV; these results, from a phase IIa trial, were
...
Sign Interferon alpha-2b Development Agreement
02 juil. 2002 05h02 HE
|
GeneMedix plc
SUFFOLK, U.K., July 2, 2002 (PRIMEZONE) -- SkyePharma PLC (LSE:SKP) (Nasdaq:SKYE) and GeneMedix plc (LSE:GMX) today announce the signature of a Joint Agreement to develop an extended release...
BioXell Announces the Discovery of a Receptor Implicated in the Development of Chronic Obstructive Pulmonary Disease
26 juin 2002 06h17 HE
|
BioXell SpA
MILAN, Italy, June 26, 2002 (PRIMEZONE) -- BioXell SpA today announced the publication of a study in the May issue of The American Journal of Respiratory and Critical Care Medicine on the...
Pharmacia: Study Shows Investigational COX-2 Specific Inhibitor Valdecoxib Causes Fewer Gastroduodenal Ulcers than the Non-Specific NSAID Diclofenac for Rheumatoid Arthritis
14 juin 2002 03h57 HE
|
Pharmacia
STOCKHOLM, Sweden, June 14, 2002 (PRIMEZONE) -- While non-specific non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used by arthritis patients to relieve pain and inflammation, (1) their...
Progress in Clinical Trial with Pharmexa's AutoVac HER-2 DNA Pharmaccine for Breast Cancer
06 juin 2002 06h16 HE
|
Pharmexa A/S
HOERSHOLM, Denmark, June 6, 2002 (PRIMEZONE) -- In July 2001 Pharmexa initiated a phase I/II clinical trial of the AutoVaca(TM) HER-2 DNA pharmaccine at clinical centers in Denmark for the treatment...
IBS Sells Pharma Software to Alloga AG in Switzerland
04 juin 2002 07h30 HE
|
IBS
STOCKHOLM, Sweden, June 4, 2002 (PRIMEZONE) -- IBS has signed a major contract with Alloga AG for IBS Pharma, IBS' specialised software solution for pharmaceutical distribution. Alloga AG is a joint...
Pharmexa Receives Top Ranking in Danish Corporate Governance Award
29 mai 2002 07h35 HE
|
Pharmexa A/S
HOERSHOLM, Denmark, May 29, 2002 (PRIMEZONE) -- The Danish Shareholders Association has announced the results of the Danish Corporate Governance Award 2002. The Award is based on 17 criteria around...
CeNeS Announces Further Progress in Its Neuropathic Pain Phase II Programme
15 mai 2002 02h31 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., May 15, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced postive interim results from Phase II trials of CNS 5161 for neuropathic pain.
Results from a single...
Wilhelm Sonesson's Information Memorandum Published
18 avr. 2002 04h43 HE
|
Wilhelm Sonesson
LUND, Sweden, April 18, 2002 (PRIMEZONE) -- As previously announced, the Board of Wilh. Sonesson has decided that it will propose to the Annual General Meeting, to be held on April 24, 2002, a...